Portfolio


RNA therapies for genetic disorders, as well as low-cost, highly accurate point-of-care molecular diagnostic solutions.

Aptah Biosciences

RNA therapies for genetic disorders, as well as low-cost, highly accurate point-of-care molecular diagnostic solutions.

Oncolytic virus therapies and gene delivery platform, based on genetically engineered Zika Virus, targeting CNS, ophthalmologic and urogenital diseases.

Vyro

Oncolytic virus therapies and gene delivery platform, based on genetically engineered Zika Virus, targeting CNS, ophthalmologic and urogenital diseases.

Next generation biofertilizers and biocontrol solutions combining artificial intelligence and gene editing tools with a proprietary database of thousands of microorganisms with plant symbiotic properties, in order to support sustainable, large scale food production.

Symbiomics

Next generation biofertilizers and biocontrol solutions combining artificial intelligence and gene editing tools with a proprietary database of thousands of microorganisms with plant symbiotic properties, in order to support sustainable, large scale food production.

Novel radiopharmaceutical therapies and diagnostics for breast and prostate cancer (Theranostics).

Radiotarget

Novel radiopharmaceutical therapies and diagnostics for breast and prostate cancer (Theranostics).

Single-dose mRNA vaccines for infectious diseases and cancer.

FutrBio

Single-dose mRNA vaccines for infectious diseases and cancer.

Non-transgenic genome editing platform that allows the creation of plants with enhanced biological capacity against plagues and abiotic stress, without the use of chemical pesticides.

InEditaBio

Non-transgenic genome editing platform that allows the creation of plants with enhanced biological capacity against plagues and abiotic stress, without the use of chemical pesticides.